Search Result "Approved drugs"
Polypharmacology of Approved Anticancer Drugs
Journal: Current Drug Targets
Volume: 18 Issue: 5 Year: 2017 Page: 534-543
Author(s): Ivano Amelio,Andrey Lisitsa,Richard A. Knight,Gerry Melino,Alexey V. Antonov
Insights into the FDA 2018 New Drug Approvals
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 2 Year: 2021 Page: 293-306
Author(s): Alaa Bedair,Fotouh R. Mansour
Drug Development Process and Novel Drugs Approved by FDA for 2017-18
Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 5 Issue: 2 Year: 2018 Page: 80-98
Author(s): Gaurav Khurana,Aashu Rohilla,Aakash Deep
Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023
Journal: Current Topics in Medicinal Chemistry
Volume: 24 Issue: 10 Year: 2024 Page: 843-849
Author(s): Andrew A. Bolinger
Approved and Marketed Fast Dissolving/ Disintegrating Drug Products
Ebook: Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms
Volume: 1 Year: 2017
Author(s): Vikas A. Saharan,Anupama Singh,Vandana Kharb
Doi: 10.2174/9781681084596117010015
US-FDA Approved Drugs in 2020 and 2021: A Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1273-1297
Author(s):
FDA Approval for Phytochemicals in the Treatment of Cancer
Ebook: Phytonutrients in the Treatment of Gastrointestinal Cancer
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815049633123010006
Insights into Newly Approved Drugs from a Medicinal Chemistry Perspective
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 16 Year: 2021 Page: 2227-2248
Author(s): Elys Juliane Cardoso Lima,Renan Augusto Gomes,Evelin Fornari,Flavio da Silva Emery,Gustavo Henrique Goulart Trossini
Pharmacological Profile of Novel Anti-cancer Drugs Approved byUSFDA in 2022: A Review
Journal: Current Molecular Medicine
Volume: 24 Issue: 6 Year: 2024 Page: 734-750
Author(s): Parveen Kumar Goyal
Regulatory Aspects of Post-Approval Safety Reporting for Generic Drug Products in the US
Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs (Discontinued)
Volume: 3 Issue: 3 Year: 2016 Page: 142-150
Author(s): Priti J. Mehta,Chandni K. Doshi